| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1800014 | 重组全人源抗人TNF-α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2018-02-13 | 武汉生物制品研究所有限责任公司 | Wuhan Institute of Biological Products Co Ltd | In Review | 2018-02-11 | view |